New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 14, 2014
10:53 EDTOVTI, CPWR, AWI, ALR, EL, RRGB, TITN, ST, CNAT, NDLSHigh option volume stocks
High option volume stocks: ALR NDLS TITN AWI CNAT RRGB CPWR ST EL OVTI
News For ALR;NDLS;TITN;AWI;CNAT;RRGB;CPWR;ST;EL;OVTI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 27, 2015
16:06 EDTCNATConatus initiated with a Buy at Brean Capital
Subscribe for More Information
15:04 EDTSTNotable companies reporting before tomorrow's open
Subscribe for More Information
10:00 EDTELOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:16 EDTELEstee Lauder upgraded on upcoming platform launch at CLSA
Subscribe for More Information
07:45 EDTEL, ELEstee Lauder upgraded to Outperform from Underperform at CLSA
Subscribe for More Information
April 23, 2015
07:19 EDTCNATConatus results at EASL meeting support emricasan registration pathway in NASH
Conatus Pharmaceuticals announced that posters providing detailed results from four recently completed clinical trials of emricasan, the company's first-in-class, orally active pan-caspase protease inhibitor, are being presented this week at The International Liver Congress 2015. Results from the company's Phase 2 double-blind, placebo-controlled clinical trial of emricasan in patients with acute-on-chronic liver failure, or ACLF, and Phase 2 double-blind, placebo-controlled clinical trial of emricasan in patients with nonalcoholic fatty liver disease, or NAFLD, including the subset of NAFLD patients with nonalcoholic steatohepatitis, or NASH, are addressed in two late-breaker posters. Conatus intends to include NASH-driven cirrhosis in its initial registration strategy for emricasan.
April 15, 2015
17:21 EDTCNATHealthCor reports 5.22% passive stake in Conatus
06:58 EDTTITNTitan Machinery says realignment costs estimated to total $2M
Subscribe for More Information
06:57 EDTTITNTitan Machinery expects to be "profitable" on EPS basis in FY16, consensus 2c
Subscribe for More Information
06:56 EDTTITNTitan Machinery says Q4 impacted by ongoing headwinds in agriculture industry
Subscribe for More Information
06:54 EDTTITNTitan Machinery reports Q4 EPS excl items (20c), consensus (19c)
Reports Q1 revenue $490.7M, consensus $545.49M. Reports Q1 equipment sales $389.6M. Reports Q1 Parts sales $50.7M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use